The development and application of a surface plasmon resonance-based inhibition immunoassay for the determination of warfarin in plasma ultrafiltrate.

[1]  H. Pieniaszek,et al.  Dose-Dependent Pharmacokinetics of Warfarin in Healthy Volunteers , 1995, Pharmaceutical Research.

[2]  Richard O'Kennedy,et al.  Production, purification and characterisation of genetically derived scFv and bifunctional antibody fragments capable of detecting illicit drug residues. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  B. Fitzpatrick.  The production, characterisation and applications of polyclonal and monoclonal antibodies to warfarin , 2001 .

[4]  J. Hirsh,et al.  Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. , 2001, Chest.

[5]  M. Morgan,et al.  Development of surface plasmon resonance-based immunoassay for aflatoxin B(1). , 2000, Journal of agricultural and food chemistry.

[6]  K D Wittrup,et al.  Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Bostick,et al.  Validation of a method for the determination of (R)-warfarin and (S)-warfarin in human plasma using LC with UV detection. , 2000, Journal of pharmaceutical and biomedical analysis.

[8]  J. W. Findlay,et al.  Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. , 2000, Journal of pharmaceutical and biomedical analysis.

[9]  F. Rüker,et al.  The Three Recombinant Domains of Human Serum Albumin , 1999, The Journal of Biological Chemistry.

[10]  L. Capitán-Vallvey,et al.  Determination of Warfarin in Waters and Human Plasma by Solid-Phase Room-Temperature Transmitted Phosphorescence , 1999, Archives of environmental contamination and toxicology.

[11]  J. Quinn,et al.  The use of regenerable, affinity ligand-based surfaces for immunosensor applications. , 1999, Biosensors & bioelectronics.

[12]  R. Valdes,et al.  Validity of unbound digoxin measurements by immunoassays in presence of antidote (Digibind). , 1999, Clinica chimica acta; international journal of clinical chemistry.

[13]  S. Thaisrivongs,et al.  Structure-based discovery of Tipranavir disodium (PNU-140690E): a potent, orally bioavailable, nonpeptidic HIV protease inhibitor. , 1999, Biopolymers.

[14]  C. Bertucci,et al.  Site I on human albumin: differences in the binding of (R)- and (S)-warfarin. , 1999, Chirality.

[15]  M. le Maire,et al.  Ligand binding to macromolecules or micelles: use of centrifugal ultrafiltration to measure low-affinity binding. , 1998, Analytical biochemistry.

[16]  S. Crooks,et al.  Immunobiosensor--an alternative to enzyme immunoassay screening for residues of two sulfonamides in pigs. , 1998, The Analyst.

[17]  D. Mytych,et al.  Validation parameters for a novel biosensor assay which simultaneously measures serum concentrations of a humanized monoclonal antibody and detects induced antibodies. , 1997, Journal of immunological methods.

[18]  R. O'Kennedy,et al.  Coumarins : biology, applications, and mode of action , 1997 .

[19]  M. Amirkhosravi,et al.  Coagulation Activation by MC28 Fibrosarcoma Cells Facilitates Lung Tumor Formation , 1995, Thrombosis and Haemostasis.

[20]  J. Hirsh,et al.  Interactions of Warfarin with Drugs and Food , 1994, Annals of Internal Medicine.

[21]  R. Karlsson,et al.  Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. , 1991, BioTechniques.

[22]  J. Zilva,et al.  Clinical chemistry in diagnosis and treatment , 1971 .

[23]  W. Henderson,et al.  Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: Final Report of VA cooperative study # 75 , 1984, Cancer.

[24]  H. Satoh,et al.  Anti‐warfarin antibody preparation and its characterization for radioimmunoassay , 1982, The Journal of pharmacy and pharmacology.

[25]  M. A. Stahmann,et al.  Studies on 4-Hydroxycoumarins. V. The Condensation of α,β-Unsaturated Ketones with 4-Hydroxycoumarin1 , 1944 .